⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL887273 | 0.90 | — | — | |
| SCHEMBL17686782 | 0.86 | — | — | |
| SCHEMBL4468517 | 0.74 | — | — | |
| SCHEMBL11574121 | 0.73 | — | — | |
| SCHEMBL3198927 | 0.70 | ALDH1A1 (0.33) | — | |
| SCHEMBL3188726 | 0.70 | ALDH1A1 (0.33) | — | |
| SCHEMBL3199147 | 0.70 | ALDH1A1 (0.33) | — | |
| SCHEMBL3180245 | 0.70 | ALDH1A1 (0.33) | — | |
| SCHEMBL3188728 | 0.70 | ALDH1A1 (0.33) | — | |
| SCHEMBL8079138 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11318206-B2 | Compounds and methods for trans-membrane delivery of molecules | APOSENSE LTD (IL) | 2022-05-03 | — | — | US | claimed |
| US-20180243426-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | APOSENSE LTD. (IL) | 2018-08-30 | — | — | US | claimed |
| EP-3337515-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | Aposense Ltd. (IL) | 2018-06-27 | — | — | EP | claimed |
| US-9889202-B2 | Compounds and methods for trans-membrane delivery of molecules | APOSENSE LTD. (IL) | 2018-02-13 | — | — | US | claimed |
| US-20170100486-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | APOSENSE LTD. (IL) | 2017-04-13 | — | — | US | claimed |
| US-20170080095-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | APOSENSE LTD. (IL) | 2017-03-23 | — | — | US | claimed |
| WO-2017029664-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | APOSENSE LTD. (IL) | 2017-02-23 | — | — | WO | claimed |
| US-20170037401-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | APOSENSE LTD. (IL) | 2017-02-09 | — | — | US | claimed |
| US-20160129125-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | APOSENSE LTD. (IL) | 2016-05-12 | — | — | US | claimed |
| US-20160120996-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | APOSENSE LTD. (IL) | 2016-05-05 | — | — | US | claimed |
| US-20160106855-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | APOSENSE LTD. (IL) | 2016-04-21 | — | — | US | claimed |
| EP-3337515-B1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | APOSENSE LTD (IL) | 2024-03-13 | — | — | EP | disclosed |
| US-11318206-B2 | Compounds and methods for trans-membrane delivery of molecules | APOSENSE LTD (IL) | 2022-05-03 | — | — | US | disclosed |
| CN-113543812-A | ADC with sulfhydryl multiple linker | 西进公司 | 2021-10-22 | — | — | CN | disclosed |
| CN-108135924-B | Compounds and methods for transmembrane delivery of molecules | 阿波森斯有限公司 | 2021-07-13 | — | — | CN | disclosed |
| EP-2543368-A1 | Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties | Viamet Pharmaceuticals, Inc. (US) | 2013-01-09 | — | — | EP | disclosed |
| US-20110015158-A1 | METALLOENZYME INHIBITORS USING METAL BINDING MOIETIES IN COMBINATION WITH TARGETING MOIETIES | VIAMET PHARMACEUTICALS, INC. (US) | 2011-01-20 | — | — | US | disclosed |
| EP-2234608-A2 | METALLOENZYME INHIBITORS USING METAL BINDING MOIETIES IN COMBINATION WITH TARGETING MOIETIES | Viamet Pharmaceuticals, Inc. (US) | 2010-10-06 | — | — | EP | disclosed |
| WO-2009105140-A2 | METALLOENZYME INHIBITORS USING METAL BINDING MOIETIES IN COMBINATION WITH TARGETING MOIETIES | VIAMET PHARMACEUTICALS, INC. (US) | 2009-08-27 | — | — | WO | disclosed |
| US-3931126-A | MODIFICATION OF CONJUGATED DIENE POLYMERS BY TREATMENT WITH ORGANOLITHIUM AND N,N,N',N'-TETRAMETHYLALKYLENEDIAMINE COMPOUNDS | PHILLIPS PETROLEUM COMPANY (US) | 1976-01-06 | — | — | US | disclosed |